Al-Omari, A., Javaid, U., Al-Omari, A., Ahmad, R. U., Imran, M., Fattah, H. A. (2026). Clinical impact of TOP1 alterations on outcomes to topoisomerase-I–directed therapies across chemotherapy and antibody-drug conjugates.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15044